Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum

A decrease in dopamine type 2 receptors (D 2 ) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D 2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [ 11C]raclopride. Fifteen AD a...

Full description

Saved in:
Bibliographic Details
Published inBiological psychiatry (1969) Vol. 58; no. 10; pp. 779 - 786
Main Authors Martinez, Diana, Gil, Roberto, Slifstein, Mark, Hwang, Dah-Ren, Huang, Yiyun, Perez, Audrey, Kegeles, Lawrence, Talbot, Peter, Evans, Suzette, Krystal, John, Laruelle, Marc, Abi-Dargham, Anissa
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 15.11.2005
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A decrease in dopamine type 2 receptors (D 2 ) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D 2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [ 11C]raclopride. Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D 2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V 3 ″). Amphetamine-induced [ 11C]raclopride displacement was measured as the difference in V 3 ″ between the two scans. [ 11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [ 11C]raclopride displacement was −5.2% ± 3.6% in AD subjects compared with −13.0% ± 8.8% in HC. However, no significant difference in [ 11C]raclopride displacement was seen in the associative (−4.6% ± 5.8% in AD subjects vs. −6.7 ± 5.4% in HC) and sensorimotor (−12.3% ± 7.3% in AD subjects vs. −13.7 ± 7.5% in HC) subdivisions of the striatum between the two groups. Alcohol dependence was associated with a decrease in D 2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.
AbstractList A decrease in dopamine type 2 receptors (D 2 ) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D 2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [ 11C]raclopride. Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D 2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V 3 ″). Amphetamine-induced [ 11C]raclopride displacement was measured as the difference in V 3 ″ between the two scans. [ 11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [ 11C]raclopride displacement was −5.2% ± 3.6% in AD subjects compared with −13.0% ± 8.8% in HC. However, no significant difference in [ 11C]raclopride displacement was seen in the associative (−4.6% ± 5.8% in AD subjects vs. −6.7 ± 5.4% in HC) and sensorimotor (−12.3% ± 7.3% in AD subjects vs. −13.7 ± 7.5% in HC) subdivisions of the striatum between the two groups. Alcohol dependence was associated with a decrease in D 2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.
A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride.BACKGROUNDA decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride.Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans.METHODSFifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans.[11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups.RESULTS[11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups.Alcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.CONCLUSIONSAlcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.
Background A decrease in dopamine type 2 receptors (D sub(2)) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D sub(2) receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [ super(11)C]raclopride. Methods Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D sub(2) receptor availability were binding potential (BP) and the equilibrium partition coefficient (V sub(3)"). Amphetamine-induced [ super(11)C]raclopride displacement was measured as the difference in V sub(3)" between the two scans. Results [ super(11)C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [ super(11)C]raclopride displacement was -5.2% plus or minus 3.6% in AD subjects compared with -13.0% plus or minus 8.8% in HC. However, no significant difference in [ super(11)C] raclopride displacement was seen in the associative (-4.6% plus or minus 5.8% in AD subjects vs. -6.7 plus or minus 5.4% in HC) and sensorimotor (-12.3% plus or minus 7.3% in AD subjects vs. -13.7 plus or minus 7.5% in HC) subdivisions of the striatum between the two groups. Conclusions Alcohol dependence was associated with a decrease in D sub(2) receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.
A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride. Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans. [11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups. Alcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.
Author Perez, Audrey
Abi-Dargham, Anissa
Huang, Yiyun
Hwang, Dah-Ren
Evans, Suzette
Slifstein, Mark
Krystal, John
Laruelle, Marc
Kegeles, Lawrence
Gil, Roberto
Martinez, Diana
Talbot, Peter
Author_xml – sequence: 1
  givenname: Diana
  surname: Martinez
  fullname: Martinez, Diana
  email: dm437@columbia.edu
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 2
  givenname: Roberto
  surname: Gil
  fullname: Gil, Roberto
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 3
  givenname: Mark
  surname: Slifstein
  fullname: Slifstein, Mark
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 4
  givenname: Dah-Ren
  surname: Hwang
  fullname: Hwang, Dah-Ren
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 5
  givenname: Yiyun
  surname: Huang
  fullname: Huang, Yiyun
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 6
  givenname: Audrey
  surname: Perez
  fullname: Perez, Audrey
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 7
  givenname: Lawrence
  surname: Kegeles
  fullname: Kegeles, Lawrence
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 8
  givenname: Peter
  surname: Talbot
  fullname: Talbot, Peter
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 9
  givenname: Suzette
  surname: Evans
  fullname: Evans, Suzette
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 10
  givenname: John
  surname: Krystal
  fullname: Krystal, John
  organization: Department of Psychiatry, Yale University, New Haven, Connecticut
– sequence: 11
  givenname: Marc
  surname: Laruelle
  fullname: Laruelle, Marc
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
– sequence: 12
  givenname: Anissa
  surname: Abi-Dargham
  fullname: Abi-Dargham, Anissa
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17296790$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16018986$$D View this record in MEDLINE/PubMed
BookMark eNqNkV1rFDEYhYNU7Lb6F8rc6N2s-ZpkBkRc-6GFghdWb7wI2cw7bNZMMk2yyv57s-xWoTcrBMILzzl5c84ZOvHBA0IXBM8JJuLter60YUpbs5pTjJs55uXwZ2hGWslqyjE9QTOMsagZpewUnaW0LqOklLxAp0Rg0natmKEfC2fCKrjqCibwPXgD1W2qFikFY3WGvvpt86r66DZ-N1yFSY_WQ3UftU-jTckGX1lf5RVU38HnqF31Ncci3Ywv0fNBuwSvDvc5-nZzfX_5ub778un2cnFXG97SXNNBsH5oOjOUBSnBTCxbzbkZhGlYz2hDZGcoLIFwoaUQg-SSAhkwl6alXLJz9GbvO8XwsIGUVVnMgHPaQ9gkJdqWNS07DpKuIVhQUcCLA7hZjtCrKdpRx616zK0Arw-ATka7oaRhbPrHSdoJ2eHCvdtzJoaUIgzK2KxzCa0kZZ0iWO3qVGv1WKfa1akwL4cXuXgi__vCMeGHvRBK7r8sRJWM3ZXb2wgmqz7Y4xbvn1gYZ70tv_0J2_8x-ANW69JF
CODEN BIPCBF
CitedBy_id crossref_primary_10_1016_j_bpsc_2015_09_005
crossref_primary_10_1111_ejn_12802
crossref_primary_10_1111_j_1530_0277_2011_01540_x
crossref_primary_10_3109_10409238_2012_735642
crossref_primary_10_1016_j_nicl_2025_103762
crossref_primary_10_1111_j_1369_1600_2011_00355_x
crossref_primary_10_1038_npp_2015_191
crossref_primary_10_3390_brainsci12020214
crossref_primary_10_1176_appi_ajp_2014_13121581
crossref_primary_10_1016_j_biopsych_2017_06_010
crossref_primary_10_1016_j_jbc_2021_101361
crossref_primary_10_1016_j_neubiorev_2022_104726
crossref_primary_10_1038_npp_2013_102
crossref_primary_10_1016_j_psychres_2015_07_005
crossref_primary_10_1017_neu_2013_46
crossref_primary_10_1038_npp_2013_347
crossref_primary_10_1152_physrev_00013_2008
crossref_primary_10_1038_npp_2017_131
crossref_primary_10_1016_j_biopsych_2019_03_965
crossref_primary_10_3390_nu12123834
crossref_primary_10_1097_FBP_0b013e32833dcfa5
crossref_primary_10_1002_syn_20806
crossref_primary_10_1016_j_ynirp_2024_100211
crossref_primary_10_1093_schbul_sbaa055
crossref_primary_10_1098_rstb_2008_0107
crossref_primary_10_1111_ejn_14313
crossref_primary_10_1016_j_drugalcdep_2016_01_001
crossref_primary_10_1111_j_1755_5949_2010_00161_x
crossref_primary_10_1016_j_neubiorev_2020_04_004
crossref_primary_10_2139_ssrn_4109815
crossref_primary_10_1007_s00702_018_1957_2
crossref_primary_10_1007_s11307_007_0086_3
crossref_primary_10_3390_s8116936
crossref_primary_10_1111_j_1530_0277_2011_01696_x
crossref_primary_10_1038_s41386_018_0191_9
crossref_primary_10_1038_s41386_018_0199_1
crossref_primary_10_1038_npp_2009_110
crossref_primary_10_1016_j_neubiorev_2013_01_018
crossref_primary_10_1523_JNEUROSCI_4322_15_2016
crossref_primary_10_1016_j_pnpbp_2015_11_004
crossref_primary_10_1177_1099800414565170
crossref_primary_10_1080_13543784_2016_1175431
crossref_primary_10_1017_neu_2013_18
crossref_primary_10_1002_da_20897
crossref_primary_10_1016_j_neuropharm_2021_108638
crossref_primary_10_1111_acer_12515
crossref_primary_10_3389_fphar_2023_1237990
crossref_primary_10_3109_02699052_2012_654591
crossref_primary_10_1016_j_gene_2022_147061
crossref_primary_10_1038_npp_2013_91
crossref_primary_10_1093_alcalc_ags047
crossref_primary_10_1111_adb_12073
crossref_primary_10_1016_j_neuropharm_2008_05_022
crossref_primary_10_1111_bcpt_70004
crossref_primary_10_1016_j_biopsych_2013_10_010
crossref_primary_10_1111_j_1530_0277_2007_00390_x
crossref_primary_10_1016_j_brainres_2017_07_014
crossref_primary_10_1111_ajad_12755
crossref_primary_10_1038_npp_2008_78
crossref_primary_10_1038_s41386_021_01157_5
crossref_primary_10_1002_da_20543
crossref_primary_10_1016_j_psychres_2014_11_078
crossref_primary_10_1016_j_pscychresns_2020_111187
crossref_primary_10_1097_JGP_0b013e318170a6d1
crossref_primary_10_3109_10408363_2011_580567
crossref_primary_10_1016_j_neuroimage_2006_11_043
crossref_primary_10_3389_fnbeh_2017_00135
crossref_primary_10_1016_j_biopsych_2012_04_036
crossref_primary_10_1016_j_neuroimage_2015_03_022
crossref_primary_10_1124_jpet_109_163501
crossref_primary_10_1016_j_jad_2009_01_021
crossref_primary_10_3389_fpsyt_2022_960238
crossref_primary_10_1007_s11682_013_9233_4
crossref_primary_10_1016_j_neuroimage_2009_07_022
crossref_primary_10_1038_jcbfm_2014_209
crossref_primary_10_1007_s00213_023_06448_x
crossref_primary_10_1016_j_nicl_2013_02_005
crossref_primary_10_1111_acer_12893
crossref_primary_10_1024_0939_5911_a000255
crossref_primary_10_1038_s41398_024_03083_8
crossref_primary_10_1111_adb_13022
crossref_primary_10_3389_fphar_2019_01593
crossref_primary_10_1016_j_bcp_2015_07_038
crossref_primary_10_1002_syn_22195
crossref_primary_10_1038_s41598_018_31531_1
crossref_primary_10_3389_fpsyt_2021_803208
crossref_primary_10_1038_npp_2012_232
crossref_primary_10_1016_j_bpsc_2018_03_018
crossref_primary_10_1016_j_neuropharm_2017_01_012
crossref_primary_10_1016_j_physbeh_2019_112574
crossref_primary_10_1016_j_conb_2013_05_001
crossref_primary_10_1016_j_neuropharm_2017_01_018
crossref_primary_10_1016_j_jpsychires_2022_06_036
crossref_primary_10_1124_pharmrev_121_000361
crossref_primary_10_1016_j_neuropharm_2014_05_016
crossref_primary_10_1111_bph_15210
crossref_primary_10_1016_j_biopsych_2024_09_028
crossref_primary_10_1016_j_euroneuro_2017_03_008
crossref_primary_10_1007_s00702_016_1561_2
crossref_primary_10_1038_npp_2017_223
crossref_primary_10_1016_j_neuroimage_2013_05_091
crossref_primary_10_1002_eat_20937
crossref_primary_10_1111_j_1530_0277_2006_00130_x
crossref_primary_10_1155_2010_909348
crossref_primary_10_1155_2019_2030751
crossref_primary_10_1186_1756_0500_6_418
crossref_primary_10_1016_j_amp_2009_10_015
crossref_primary_10_1016_j_drugalcdep_2020_108432
crossref_primary_10_1038_s41467_025_56715_y
crossref_primary_10_1111_ejn_13390
crossref_primary_10_1016_j_nicl_2020_102297
crossref_primary_10_1016_j_pharmthera_2012_01_010
crossref_primary_10_1073_pnas_1412314111
crossref_primary_10_1111_j_1530_0277_2012_01851_x
crossref_primary_10_1002_ana_21364
crossref_primary_10_1007_s11469_017_9803_6
crossref_primary_10_1016_j_biopsych_2016_05_018
crossref_primary_10_1016_j_pscychresns_2007_12_001
crossref_primary_10_1177_0271678X16629483
crossref_primary_10_1016_j_neuroimage_2010_02_006
crossref_primary_10_1371_journal_pone_0099454
crossref_primary_10_1007_s00213_011_2543_6
crossref_primary_10_1080_14656566_2023_2266359
crossref_primary_10_1016_j_psychres_2020_113563
crossref_primary_10_1111_j_1530_0277_2010_01199_x
crossref_primary_10_1097_HTR_0000000000000508
crossref_primary_10_1159_000362838
crossref_primary_10_1192_bjp_bp_107_041228
crossref_primary_10_1038_s41386_021_01095_2
crossref_primary_10_1016_j_neuron_2013_06_006
crossref_primary_10_2967_jnumed_111_098186
crossref_primary_10_1111_adb_13239
crossref_primary_10_1371_journal_pone_0076905
crossref_primary_10_1016_j_biopsych_2011_12_018
crossref_primary_10_1016_j_euroneuro_2013_01_009
crossref_primary_10_1038_jcbfm_2012_20
crossref_primary_10_1007_s00406_019_01072_3
crossref_primary_10_1016_j_alcohol_2020_07_004
crossref_primary_10_1038_npp_2015_110
crossref_primary_10_1016_j_pnpbp_2007_08_027
crossref_primary_10_1038_bjp_2008_101
crossref_primary_10_1515_RNS_2011_055
crossref_primary_10_1080_14459795_2018_1448428
crossref_primary_10_1111_j_1530_0277_2011_01567_x
crossref_primary_10_1016_j_biopsych_2010_06_005
crossref_primary_10_1196_annals_1441_030
crossref_primary_10_1038_mp_2013_163
crossref_primary_10_1016_j_drugalcdep_2012_07_016
crossref_primary_10_1016_j_psc_2012_03_011
crossref_primary_10_1016_j_neulet_2007_11_074
crossref_primary_10_1093_alcalc_agl037
crossref_primary_10_1111_j_1369_1600_2008_00134_x
crossref_primary_10_1038_npp_2014_301
crossref_primary_10_1016_j_biopsych_2011_05_035
crossref_primary_10_1523_JNEUROSCI_3371_07_2007
crossref_primary_10_3389_fphar_2014_00161
crossref_primary_10_1002_syn_20404
crossref_primary_10_1002_syn_22023
crossref_primary_10_1016_j_pbb_2014_03_006
crossref_primary_10_1016_j_neuron_2013_07_018
crossref_primary_10_1016_j_neuroimage_2017_01_045
crossref_primary_10_1038_s41386_024_01821_6
crossref_primary_10_1016_j_psychres_2019_112542
crossref_primary_10_1111_adb_13219
crossref_primary_10_1016_j_neuropharm_2013_06_031
crossref_primary_10_1038_s41386_019_0456_y
crossref_primary_10_1016_j_cpr_2016_02_001
crossref_primary_10_1097_JCP_0b013e3181e75cff
crossref_primary_10_1176_appi_ajp_20220819
crossref_primary_10_1016_j_pnpbp_2013_10_013
crossref_primary_10_1016_j_physbeh_2009_03_020
crossref_primary_10_1007_s00213_014_3850_5
crossref_primary_10_1016_j_dcn_2021_100944
crossref_primary_10_1016_j_mcn_2017_09_007
crossref_primary_10_1016_j_neulet_2018_08_010
crossref_primary_10_1016_j_alcohol_2007_11_004
crossref_primary_10_1080_09540260902962164
crossref_primary_10_1038_tp_2016_6
crossref_primary_10_1016_j_bbr_2016_05_045
crossref_primary_10_1111_adb_12915
crossref_primary_10_1016_j_pscychresns_2011_11_001
crossref_primary_10_1177_0269881114531664
crossref_primary_10_1111_acer_13568
crossref_primary_10_1073_pnas_1411228111
crossref_primary_10_1016_j_alcohol_2011_02_306
crossref_primary_10_1111_ejn_14160
crossref_primary_10_1111_adb_70008
crossref_primary_10_1016_j_dcn_2019_100618
crossref_primary_10_1016_j_expneurol_2019_03_012
crossref_primary_10_1016_j_neuroimage_2010_11_071
crossref_primary_10_1007_s00702_019_01985_2
crossref_primary_10_1111_psyp_14118
crossref_primary_10_1038_mp_2012_109
crossref_primary_10_1016_j_neuropharm_2013_07_039
crossref_primary_10_1002_syn_20628
crossref_primary_10_1016_j_neuroimage_2011_07_002
crossref_primary_10_1016_j_neuint_2019_01_022
crossref_primary_10_1038_s41380_018_0107_4
crossref_primary_10_1002_syn_20874
crossref_primary_10_1111_j_1360_0443_2010_03022_x
crossref_primary_10_1176_appi_ps_201900561
crossref_primary_10_1176_appi_ajp_2020_19070703
crossref_primary_10_1016_j_neuroimage_2020_117154
crossref_primary_10_1073_pnas_1506012113
crossref_primary_10_1111_adb_12341
crossref_primary_10_1111_j_1530_0277_2007_00605_x
crossref_primary_10_1016_j_biopsych_2006_01_008
crossref_primary_10_1002_eat_20984
crossref_primary_10_1016_j_biopsych_2022_05_024
crossref_primary_10_1016_j_euroneuro_2006_02_002
crossref_primary_10_1016_j_mehy_2005_12_003
crossref_primary_10_3389_fpsyt_2019_00626
crossref_primary_10_1177_0271678X17719390
crossref_primary_10_1016_j_drugalcdep_2019_107627
crossref_primary_10_1038_sj_npp_1301400
crossref_primary_10_1111_j_1369_1600_2008_00136_x
crossref_primary_10_1093_ntr_ntab208
crossref_primary_10_1016_j_neulet_2020_135551
crossref_primary_10_1080_00952990_2016_1257633
crossref_primary_10_1016_j_mehy_2008_02_006
crossref_primary_10_1016_j_neuroimage_2014_04_060
crossref_primary_10_1002_mds_23227
crossref_primary_10_1371_journal_pone_0073903
crossref_primary_10_1016_j_biopsych_2022_03_008
crossref_primary_10_1016_j_schres_2012_07_024
crossref_primary_10_1371_journal_pone_0198935
crossref_primary_10_1038_ijo_2016_9
crossref_primary_10_1038_s41467_018_03272_2
crossref_primary_10_1038_tp_2015_139
crossref_primary_10_3389_fnbeh_2014_00141
crossref_primary_10_1016_j_alcohol_2018_05_011
crossref_primary_10_1038_npp_2015_11
crossref_primary_10_1038_s41380_018_0230_2
crossref_primary_10_1016_j_nic_2007_07_004
crossref_primary_10_1038_npp_2017_298
crossref_primary_10_1016_j_drugalcdep_2014_08_016
crossref_primary_10_1038_nrn3939
crossref_primary_10_1371_journal_pone_0171170
crossref_primary_10_3389_fpsyt_2024_1373866
crossref_primary_10_1007_s11920_011_0224_0
crossref_primary_10_1021_cn300013p
crossref_primary_10_1016_j_addbeh_2020_106760
crossref_primary_10_1523_JNEUROSCI_5029_12_2013
crossref_primary_10_7202_1027830ar
crossref_primary_10_1016_j_neubiorev_2017_02_010
crossref_primary_10_1038_s41598_022_25653_w
crossref_primary_10_1002_syn_20734
crossref_primary_10_1016_j_euroneuro_2015_06_002
crossref_primary_10_1016_j_pharmthera_2020_107573
crossref_primary_10_1016_j_bpsc_2016_06_005
crossref_primary_10_3389_fphar_2019_01087
crossref_primary_10_1007_s00259_021_05448_3
crossref_primary_10_1111_j_1530_0277_2012_01772_x
crossref_primary_10_1007_BF03033360
crossref_primary_10_1016_j_biopsych_2013_08_033
crossref_primary_10_1111_j_1530_0277_2011_01520_x
crossref_primary_10_3389_fmicb_2022_916765
crossref_primary_10_1016_j_neubiorev_2018_09_010
crossref_primary_10_1038_npp_2010_237
crossref_primary_10_1111_add_12066
crossref_primary_10_1016_j_neuroimage_2007_12_063
crossref_primary_10_1038_npp_2008_104
crossref_primary_10_1016_j_biopsych_2011_08_024
crossref_primary_10_1053_j_semnuclmed_2016_09_003
crossref_primary_10_1523_JNEUROSCI_2157_21_2022
crossref_primary_10_1093_ijnp_pyv074
crossref_primary_10_1111_j_1530_0277_2007_00406_x
crossref_primary_10_3389_fpsyt_2019_00176
crossref_primary_10_1016_j_mri_2007_02_017
crossref_primary_10_1016_j_physbeh_2006_03_014
crossref_primary_10_1038_s41591_023_02463_9
crossref_primary_10_1111_adb_12671
crossref_primary_10_1007_s00213_019_05345_6
crossref_primary_10_3389_fnint_2022_884080
crossref_primary_10_1002_syn_21916
crossref_primary_10_1016_j_bbi_2011_01_008
crossref_primary_10_1016_j_drugalcdep_2021_108565
crossref_primary_10_1016_j_neuroimage_2016_07_055
crossref_primary_10_1016_j_schres_2009_06_010
crossref_primary_10_1111_adb_12300
crossref_primary_10_1002_mds_27953
crossref_primary_10_1111_adb_12304
crossref_primary_10_1007_s00115_006_2067_1
crossref_primary_10_1007_s00213_014_3662_7
crossref_primary_10_3390_nu13113938
crossref_primary_10_1016_j_cell_2015_07_046
Cites_doi 10.1073/pnas.90.17.7966
10.1038/sj.npp.1380111
10.1111/j.1530-0277.2001.tb02199.x
10.1176/ajp.147.6.719
10.1176/ajp.157.1.127
10.1111/j.1360-0443.2005.00960.x
10.1046/j.1471-4159.2001.00492.x
10.1016/S0969-8051(01)00214-1
10.1016/0306-4603(82)90022-3
10.1111/j.1530-0277.1995.tb01475.x
10.1016/0091-3057(82)90026-0
10.1176/appi.ajp.158.12.2015
10.1073/pnas.94.6.2569
10.1523/JNEUROSCI.12-10-03773.1992
10.1007/s002130051173
10.1038/sj.mp.4000365
10.1016/S0893-133X(96)00184-4
10.1016/0741-8329(95)00010-O
10.1097/00004647-200109000-00002
10.1002/syn.20062
10.1016/S0925-4927(02)00087-2
10.1002/ana.410440307
10.1176/ajp.161.10.1783
10.1016/0301-0082(94)90025-6
10.1016/0741-8329(93)90025-J
10.1016/S0304-3940(00)01423-3
10.1046/j.1360-0443.95.8s2.9.x
10.1016/S0006-8993(02)03220-1
10.1016/S0893-133X(97)00043-2
10.1176/ajp.127.12.1653
10.1038/sj.mp.4000859
10.1016/S0140-6736(00)03643-6
10.1007/BF02245330
10.1016/0091-3057(88)90291-2
10.1002/hbm.10129
10.1097/01.WCB.0000048520.34839.1A
10.1046/j.1471-4159.2003.01732.x
10.1037/0021-843X.91.3.199
10.1007/s00213-002-1233-9
10.1038/347146a0
10.1037/0021-843X.97.2.118
10.1002/syn.10226
10.1007/s002130050356
ContentType Journal Article
Copyright 2005 Society of Biological Psychiatry
2006 INIST-CNRS
Copyright_xml – notice: 2005 Society of Biological Psychiatry
– notice: 2006 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7X8
DOI 10.1016/j.biopsych.2005.04.044
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

Neurosciences Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
EISSN 1873-2402
EndPage 786
ExternalDocumentID 16018986
17296790
10_1016_j_biopsych_2005_04_044
S0006322305005640
Genre Journal Article
Comparative Study
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAAA NIH HHS
  grantid: R01 AA12759-0
– fundername: NCRR NIH HHS
  grantid: RR00645
GroupedDBID ---
--K
--M
-DZ
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABCQX
ABDPE
ABFNM
ABFRF
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACIEU
ACIUM
ACNCT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEG
HMK
HMO
HMQ
HVGLF
HZ~
H~9
IHE
J1W
KOM
L7B
M29
M2V
M39
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OH0
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SNS
SPCBC
SSH
SSN
SSZ
T5K
UAP
UNMZH
UPT
UV1
WH7
WUQ
XJT
XOL
Z5R
ZCA
ZGI
ZKB
ZXP
~G-
AACTN
AADPK
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
G8K
LCYCR
RIG
ZA5
AAYXX
AGRNS
CITATION
08R
ABPIF
ABPTK
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7TK
7X8
ID FETCH-LOGICAL-c482t-2f63df59cf00021036b8a44cf6c53d325179c2ebe146a766f7472e1f047c82473
IEDL.DBID .~1
ISSN 0006-3223
IngestDate Thu Jul 10 23:04:16 EDT 2025
Fri Jul 11 02:03:46 EDT 2025
Wed Feb 19 01:52:23 EST 2025
Sun Oct 22 16:05:37 EDT 2023
Thu Apr 24 23:03:50 EDT 2025
Tue Jul 01 03:21:07 EDT 2025
Fri Feb 23 02:31:31 EST 2024
Tue Aug 26 16:31:37 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords amphetamine
Alcohol dependence
mesolimbic
positron emission tomography (PET)
dopamine
ventral striatum
Amphetamine derivatives
Radionuclide study
Human
Dopamine
CNS stimulant
Psychotropic
Alcoholism
Central nervous system
Basal ganglion
Corpus striatum
Catecholamine
Encephalon
Chemotherapy
Treatment
Neurotransmitter
Amfetamine
Emission tomography
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c482t-2f63df59cf00021036b8a44cf6c53d325179c2ebe146a766f7472e1f047c82473
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 16018986
PQID 19510626
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_68835837
proquest_miscellaneous_19510626
pubmed_primary_16018986
pascalfrancis_primary_17296790
crossref_citationtrail_10_1016_j_biopsych_2005_04_044
crossref_primary_10_1016_j_biopsych_2005_04_044
elsevier_sciencedirect_doi_10_1016_j_biopsych_2005_04_044
elsevier_clinicalkey_doi_10_1016_j_biopsych_2005_04_044
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2005-11-15
PublicationDateYYYYMMDD 2005-11-15
PublicationDate_xml – month: 11
  year: 2005
  text: 2005-11-15
  day: 15
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Biological psychiatry (1969)
PublicationTitleAlternate Biol Psychiatry
PublicationYear 2005
Publisher Elsevier Inc
Elsevier Science
Publisher_xml – name: Elsevier Inc
– name: Elsevier Science
References Volkow, Wang, Fowler, Logan, Hitzemann, Ding (bib42) 1996; 37
Hall, Sedvall, Magnusson, Kopp, Halldin, Farde (bib11) 1994; 11
Slifstein, Narendran, Hwang, Sudo, Talbot, Huang, Laruelle (bib34) 2004; 54
Volkow, Fowler, Wolf, Schlyer, Shiue, Alpert (bib41) 1990; 147
Hwang, Narendran, Huang, Slifstein, Talbot, Sudo (bib15) 2004; 45
Patel, Mooslehner, Chan, Emson, Stamford (bib26) 2003; 85
Boileau, Assaad, Pihl, Benkelfat, Leyton, Diksic (bib3) 2003; 49
Bradberry (bib4) 2002; 165
Mawlawi, Martinez, Slifstein, Broft, Chatterjee, Hwang (bib22) 2001; 21
Wang, Volkow, Logan, Pappas, Wong, Zhu (bib45) 2001; 357
Wang, Volkow, Fowler, Logan, Abumrad, Hitzemann (bib44) 1997; 16
Martinez, Slifstein, Broft, Mawlawi, Hwang, Huang (bib21) 2003; 23
Pennartz, Groenewegen, Lopes da Silva (bib27) 1994; 42
Anton (bib1) 2000; 95
Katner, Weiss (bib17) 2001; 25
Rousset, Ma, Evans (bib30) 1998; 39
Hietala, Kuoppamaki, Nagren, Lehikoinen, Syvalahti (bib13) 1997; 132
Sokoloff, Giros, Martres, Bouthenet, Schwartz (bib35) 1990; 347
Heinz, Siessmeier, Wrase, Hermann, Klein, Grusser (bib12) 2004; 161
Raabe, Grusser, Wessa, Podschus, Flor (bib28) 2005; 100
Laruelle, DSouza, Baldwin, AbiDargham, Kanes, Fingado (bib19) 1997; 17
Diana, Pistis, Carboni, Gessa, Rossetti (bib8) 1993; 90
Dewey, Smith, Logan, Brodie, Yu, Ferrieri (bib7) 1992; 12
Guardia, Catafau, Batlle, Martin, Segura, Gonzalvo (bib10) 2000; 157
Murphy, McBride, Lumeng, Li (bib25) 1982; 16
Tupala, Hall, Bergstrom, Mantere, Rasanen, Sarkioja, Tiihonen (bib38) 2003; 20
Casu, Dinucci, Colombo, Gessa, Pani (bib6) 2002; 948
Hietala, West, Syvalahti, Nagren, Lehikoinen, Sonninen, Ruotsalainen (bib14) 1994; 116
Skinner, Allen (bib32) 1982; 91
Gilman, Koeppe, Adams, Junck, Kluin, Johnson-Greene (bib9) 1998; 44
Repo, Kuikka, Bergstrom, Karhu, Hiltunen, Tiihonen (bib29) 1999; 147
Slifstein, Laruelle (bib33) 2001; 28
Tiihonen, Vilkman, Rasanen, Ryynanen, Hakko, Bergman (bib37) 1998; 3
Tupala, Hall, Bergstrom, Sarkioja, Rasanen, Mantere (bib39) 2001; 6
Wise (bib46) 1988; 2
McBride, Chernet, Dyr, Lumeng, Li (bib23) 1993; 10
Breier, Su, Saunders, Carson, Kolachana, deBartolomeis (bib5) 1997; 94
Volkow, Wang, Maynard, Fowler, Jayne, Telang (bib43) 2002; 116
Kuikka, Repo, Bergstrom, Tupala, Tiihonen (bib18) 2000; 292
Anton, Moak, Latham (bib2) 1995; 19
Thanos, Volkow, Freimuth, Umegaki, Ikari, Roth (bib36) 2001; 78
Murphy, McBride, Gatto, Lumeng, Li (bib24) 1988; 29
Maisto, Sobell, Cooper, Sobell (bib20) 1982; 7
Zhou, Zhang, Lumeng, Li (bib47) 1995; 12
Selzer (bib31) 1971; 127
Volkow, Chang, Wang, Fowler, Ding, Sedler (bib40) 2001; 158
Imperato, Di Chiara (bib16) 1986; 239
Katner (10.1016/j.biopsych.2005.04.044_bib17) 2001; 25
Heinz (10.1016/j.biopsych.2005.04.044_bib12) 2004; 161
Casu (10.1016/j.biopsych.2005.04.044_bib6) 2002; 948
Mawlawi (10.1016/j.biopsych.2005.04.044_bib22) 2001; 21
Patel (10.1016/j.biopsych.2005.04.044_bib26) 2003; 85
Martinez (10.1016/j.biopsych.2005.04.044_bib21) 2003; 23
Kuikka (10.1016/j.biopsych.2005.04.044_bib18) 2000; 292
Wise (10.1016/j.biopsych.2005.04.044_bib46) 1988; 2
Murphy (10.1016/j.biopsych.2005.04.044_bib24) 1988; 29
Repo (10.1016/j.biopsych.2005.04.044_bib29) 1999; 147
McBride (10.1016/j.biopsych.2005.04.044_bib23) 1993; 10
Slifstein (10.1016/j.biopsych.2005.04.044_bib34) 2004; 54
Murphy (10.1016/j.biopsych.2005.04.044_bib25) 1982; 16
Tiihonen (10.1016/j.biopsych.2005.04.044_bib37) 1998; 3
Zhou (10.1016/j.biopsych.2005.04.044_bib47) 1995; 12
Diana (10.1016/j.biopsych.2005.04.044_bib8) 1993; 90
Bradberry (10.1016/j.biopsych.2005.04.044_bib4) 2002; 165
Tupala (10.1016/j.biopsych.2005.04.044_bib38) 2003; 20
Volkow (10.1016/j.biopsych.2005.04.044_bib42) 1996; 37
Volkow (10.1016/j.biopsych.2005.04.044_bib41) 1990; 147
Slifstein (10.1016/j.biopsych.2005.04.044_bib33) 2001; 28
Volkow (10.1016/j.biopsych.2005.04.044_bib40) 2001; 158
Breier (10.1016/j.biopsych.2005.04.044_bib5) 1997; 94
Laruelle (10.1016/j.biopsych.2005.04.044_bib19) 1997; 17
Guardia (10.1016/j.biopsych.2005.04.044_bib10) 2000; 157
Hietala (10.1016/j.biopsych.2005.04.044_bib13) 1997; 132
Hietala (10.1016/j.biopsych.2005.04.044_bib14) 1994; 116
Dewey (10.1016/j.biopsych.2005.04.044_bib7) 1992; 12
Volkow (10.1016/j.biopsych.2005.04.044_bib43) 2002; 116
Anton (10.1016/j.biopsych.2005.04.044_bib2) 1995; 19
Sokoloff (10.1016/j.biopsych.2005.04.044_bib35) 1990; 347
Selzer (10.1016/j.biopsych.2005.04.044_bib31) 1971; 127
Wang (10.1016/j.biopsych.2005.04.044_bib45) 2001; 357
Hwang (10.1016/j.biopsych.2005.04.044_bib15) 2004; 45
Skinner (10.1016/j.biopsych.2005.04.044_bib32) 1982; 91
Gilman (10.1016/j.biopsych.2005.04.044_bib9) 1998; 44
Raabe (10.1016/j.biopsych.2005.04.044_bib28) 2005; 100
Pennartz (10.1016/j.biopsych.2005.04.044_bib27) 1994; 42
Wang (10.1016/j.biopsych.2005.04.044_bib44) 1997; 16
Boileau (10.1016/j.biopsych.2005.04.044_bib3) 2003; 49
Imperato (10.1016/j.biopsych.2005.04.044_bib16) 1986; 239
Tupala (10.1016/j.biopsych.2005.04.044_bib39) 2001; 6
Rousset (10.1016/j.biopsych.2005.04.044_bib30) 1998; 39
Thanos (10.1016/j.biopsych.2005.04.044_bib36) 2001; 78
Hall (10.1016/j.biopsych.2005.04.044_bib11) 1994; 11
Maisto (10.1016/j.biopsych.2005.04.044_bib20) 1982; 7
Anton (10.1016/j.biopsych.2005.04.044_bib1) 2000; 95
References_xml – volume: 85
  start-page: 898
  year: 2003
  end-page: 910
  ident: bib26
  article-title: Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice
  publication-title: J Neurochem
– volume: 6
  start-page: 261
  year: 2001
  end-page: 267
  ident: bib39
  article-title: Dopamine D(2)/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics
  publication-title: Mol Psychiatry
– volume: 90
  start-page: 7966
  year: 1993
  end-page: 7969
  ident: bib8
  article-title: Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats
  publication-title: Proc Natl Acad Sci U S A
– volume: 45
  start-page: 338
  year: 2004
  end-page: 346
  ident: bib15
  article-title: Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates
  publication-title: J Nucl Med
– volume: 42
  start-page: 719
  year: 1994
  end-page: 761
  ident: bib27
  article-title: The nucleus accumbens as a complex of functionally distinct neuronal ensembles
  publication-title: Prog Neurobiol
– volume: 116
  start-page: 163
  year: 2002
  end-page: 172
  ident: bib43
  article-title: Effects of alcohol detoxification on dopamine D
  publication-title: Psychiatry Res
– volume: 158
  start-page: 2015
  year: 2001
  end-page: 2021
  ident: bib40
  article-title: Low level of brain dopamine D
  publication-title: Am J Psychiatry
– volume: 7
  start-page: 33
  year: 1982
  end-page: 38
  ident: bib20
  article-title: Comparison of two techniques to obtain retrospective reports of drinking behavior from alcohol abusers
  publication-title: Addict Behav
– volume: 19
  start-page: 92
  year: 1995
  end-page: 99
  ident: bib2
  article-title: The Obsessive Compulsive Drinking Scale
  publication-title: Alcohol Clin Exp Res
– volume: 94
  start-page: 2569
  year: 1997
  end-page: 2574
  ident: bib5
  article-title: Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations
  publication-title: Proc Natl Acad Sci U S A
– volume: 132
  start-page: 361
  year: 1997
  end-page: 365
  ident: bib13
  article-title: Effects of lorazepam administration on striatal dopamine D–2 receptor binding characteristics in man—a positron emission tomography study
  publication-title: Psychopharmacology
– volume: 25
  start-page: 198
  year: 2001
  end-page: 205
  ident: bib17
  article-title: Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats
  publication-title: Alcohol Clin Exp Res
– volume: 21
  start-page: 1034
  year: 2001
  end-page: 1057
  ident: bib22
  article-title: Imaging human mesolimbic dopamine transmission with PET
  publication-title: J Cereb Blood Flow Metab
– volume: 116
  start-page: 285
  year: 1994
  end-page: 290
  ident: bib14
  article-title: Striatal D
  publication-title: Psychopharmacology (Berl)
– volume: 147
  start-page: 719
  year: 1990
  end-page: 724
  ident: bib41
  article-title: Effects of chronic cocaine abuse on postsynaptic dopamine receptors
  publication-title: Am J Psychiatry
– volume: 20
  start-page: 91
  year: 2003
  end-page: 102
  ident: bib38
  article-title: Dopamine D
  publication-title: Hum Brain Mapp
– volume: 347
  start-page: 146
  year: 1990
  end-page: 151
  ident: bib35
  article-title: Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics
  publication-title: Nature
– volume: 11
  start-page: 245
  year: 1994
  end-page: 256
  ident: bib11
  article-title: Distribution of D1- and D
  publication-title: Neuropsychopharmacology
– volume: 12
  start-page: 3773
  year: 1992
  end-page: 3780
  ident: bib7
  article-title: GABAergic inhibition of endogenous dopamine release measured in vivo with
  publication-title: J Neurosci
– volume: 100
  start-page: 227
  year: 2005
  end-page: 234
  ident: bib28
  article-title: The assessment of craving
  publication-title: Addiction
– volume: 239
  start-page: 219
  year: 1986
  end-page: 228
  ident: bib16
  article-title: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol
  publication-title: J Pharmacol Exp Ther
– volume: 17
  start-page: 162
  year: 1997
  end-page: 174
  ident: bib19
  article-title: Imaging D–2 receptor occupancy by endogenous dopamine in humans
  publication-title: Neuropsychopharmacology
– volume: 28
  start-page: 595
  year: 2001
  end-page: 608
  ident: bib33
  article-title: Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers
  publication-title: Nucl Med Biol
– volume: 54
  start-page: 46
  year: 2004
  end-page: 63
  ident: bib34
  article-title: Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain
  publication-title: Synapse
– volume: 165
  start-page: 67
  year: 2002
  end-page: 76
  ident: bib4
  article-title: Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys
  publication-title: Psychopharmacology (Berl)
– volume: 49
  start-page: 226
  year: 2003
  end-page: 231
  ident: bib3
  article-title: Alcohol promotes dopamine release in the human nucleus accumbens
  publication-title: Synapse
– volume: 157
  start-page: 127
  year: 2000
  end-page: 129
  ident: bib10
  article-title: Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients
  publication-title: Am J Psychiatry
– volume: 16
  start-page: 174
  year: 1997
  end-page: 182
  ident: bib44
  article-title: Dopamine D
  publication-title: Neuropsychopharmacology
– volume: 23
  start-page: 285
  year: 2003
  end-page: 300
  ident: bib21
  article-title: Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum
  publication-title: J Cereb Blood Flow Metab
– volume: 948
  start-page: 192
  year: 2002
  end-page: 202
  ident: bib6
  article-title: Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats
  publication-title: Brain Res
– volume: 161
  start-page: 1783
  year: 2004
  end-page: 1789
  ident: bib12
  article-title: Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving
  publication-title: Am J Psychiatry
– volume: 44
  start-page: 326
  year: 1998
  end-page: 333
  ident: bib9
  article-title: Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[
  publication-title: Ann Neurol
– volume: 10
  start-page: 387
  year: 1993
  end-page: 390
  ident: bib23
  article-title: Densities of dopamine D
  publication-title: Alcohol
– volume: 3
  start-page: 156
  year: 1998
  end-page: 161
  ident: bib37
  article-title: Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography
  publication-title: Mol Psychiatry
– volume: 78
  start-page: 1094
  year: 2001
  end-page: 1103
  ident: bib36
  article-title: Overexpression of dopamine D
  publication-title: J Neurochem
– volume: 292
  start-page: 57
  year: 2000
  end-page: 59
  ident: bib18
  article-title: Specific binding and laterality of human extrastriatal dopamine D2/D3 receptors in late onset type 1 alcoholic patients
  publication-title: Neurosci Lett
– volume: 91
  start-page: 199
  year: 1982
  end-page: 209
  ident: bib32
  article-title: Alcohol dependence syndrome
  publication-title: J Abnorm Psychol
– volume: 357
  start-page: 354
  year: 2001
  end-page: 357
  ident: bib45
  article-title: Brain dopamine and obesity
  publication-title: Lancet
– volume: 2
  start-page: 118
  year: 1988
  end-page: 132
  ident: bib46
  article-title: The neurobiology of craving
  publication-title: J Abnorm Psychol
– volume: 16
  start-page: 145
  year: 1982
  end-page: 149
  ident: bib25
  article-title: Regional brain levels of monoamines in alcohol-preferring and -nonpreferring lines of rats
  publication-title: Pharmacol Biochem Behav
– volume: 127
  start-page: 1653
  year: 1971
  end-page: 1658
  ident: bib31
  article-title: The Michigan alcoholism screening test
  publication-title: Am J Psychiatry
– volume: 95
  start-page: S211
  year: 2000
  end-page: S217
  ident: bib1
  article-title: Obsessive–compulsive aspects of craving
  publication-title: Addiction
– volume: 37
  start-page: 33P
  year: 1996
  ident: bib42
  article-title: Decreases in dopamine receptors but not in dopamine transporters in alcoholics
  publication-title: J Nucl Med
– volume: 12
  start-page: 403
  year: 1995
  end-page: 412
  ident: bib47
  article-title: Mesolimbic dopamine system in alcohol-preferring rats
  publication-title: Alcohol
– volume: 39
  start-page: 904
  year: 1998
  end-page: 911
  ident: bib30
  article-title: Correction for partial volume effects in PET
  publication-title: J Nucl Med
– volume: 29
  start-page: 169
  year: 1988
  end-page: 174
  ident: bib24
  article-title: Effects of acute ethanol administration on monoamine and metabolite content in forebrain regions of ethanol-tolerant and -nontolerant alcohol-preferring (P) rats
  publication-title: Pharmacol Biochem Behav
– volume: 147
  start-page: 314
  year: 1999
  end-page: 318
  ident: bib29
  article-title: Dopamine transporter and D
  publication-title: Psychopharmacology (Berl)
– volume: 90
  start-page: 7966
  year: 1993
  ident: 10.1016/j.biopsych.2005.04.044_bib8
  article-title: Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.90.17.7966
– volume: 11
  start-page: 245
  year: 1994
  ident: 10.1016/j.biopsych.2005.04.044_bib11
  article-title: Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1380111
– volume: 25
  start-page: 198
  year: 2001
  ident: 10.1016/j.biopsych.2005.04.044_bib17
  article-title: Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2001.tb02199.x
– volume: 147
  start-page: 719
  year: 1990
  ident: 10.1016/j.biopsych.2005.04.044_bib41
  article-title: Effects of chronic cocaine abuse on postsynaptic dopamine receptors
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.147.6.719
– volume: 157
  start-page: 127
  year: 2000
  ident: 10.1016/j.biopsych.2005.04.044_bib10
  article-title: Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.157.1.127
– volume: 100
  start-page: 227
  year: 2005
  ident: 10.1016/j.biopsych.2005.04.044_bib28
  article-title: The assessment of craving
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2005.00960.x
– volume: 78
  start-page: 1094
  year: 2001
  ident: 10.1016/j.biopsych.2005.04.044_bib36
  article-title: Overexpression of dopamine D2 receptors reduces alcohol self-administration
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2001.00492.x
– volume: 39
  start-page: 904
  year: 1998
  ident: 10.1016/j.biopsych.2005.04.044_bib30
  article-title: Correction for partial volume effects in PET
  publication-title: J Nucl Med
– volume: 28
  start-page: 595
  year: 2001
  ident: 10.1016/j.biopsych.2005.04.044_bib33
  article-title: Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers
  publication-title: Nucl Med Biol
  doi: 10.1016/S0969-8051(01)00214-1
– volume: 7
  start-page: 33
  year: 1982
  ident: 10.1016/j.biopsych.2005.04.044_bib20
  article-title: Comparison of two techniques to obtain retrospective reports of drinking behavior from alcohol abusers
  publication-title: Addict Behav
  doi: 10.1016/0306-4603(82)90022-3
– volume: 19
  start-page: 92
  year: 1995
  ident: 10.1016/j.biopsych.2005.04.044_bib2
  article-title: The Obsessive Compulsive Drinking Scale
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.1995.tb01475.x
– volume: 16
  start-page: 145
  year: 1982
  ident: 10.1016/j.biopsych.2005.04.044_bib25
  article-title: Regional brain levels of monoamines in alcohol-preferring and -nonpreferring lines of rats
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(82)90026-0
– volume: 158
  start-page: 2015
  year: 2001
  ident: 10.1016/j.biopsych.2005.04.044_bib40
  article-title: Low level of brain dopamine D2 receptors in methamphetamine abusers
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.158.12.2015
– volume: 94
  start-page: 2569
  year: 1997
  ident: 10.1016/j.biopsych.2005.04.044_bib5
  article-title: Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.94.6.2569
– volume: 12
  start-page: 3773
  year: 1992
  ident: 10.1016/j.biopsych.2005.04.044_bib7
  article-title: GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.12-10-03773.1992
– volume: 147
  start-page: 314
  year: 1999
  ident: 10.1016/j.biopsych.2005.04.044_bib29
  article-title: Dopamine transporter and D2-receptor density in late-onset alcoholism
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s002130051173
– volume: 3
  start-page: 156
  year: 1998
  ident: 10.1016/j.biopsych.2005.04.044_bib37
  article-title: Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4000365
– volume: 16
  start-page: 174
  year: 1997
  ident: 10.1016/j.biopsych.2005.04.044_bib44
  article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(96)00184-4
– volume: 12
  start-page: 403
  year: 1995
  ident: 10.1016/j.biopsych.2005.04.044_bib47
  article-title: Mesolimbic dopamine system in alcohol-preferring rats
  publication-title: Alcohol
  doi: 10.1016/0741-8329(95)00010-O
– volume: 21
  start-page: 1034
  year: 2001
  ident: 10.1016/j.biopsych.2005.04.044_bib22
  article-title: Imaging human mesolimbic dopamine transmission with PET
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1097/00004647-200109000-00002
– volume: 54
  start-page: 46
  year: 2004
  ident: 10.1016/j.biopsych.2005.04.044_bib34
  article-title: Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain
  publication-title: Synapse
  doi: 10.1002/syn.20062
– volume: 37
  start-page: 33P
  year: 1996
  ident: 10.1016/j.biopsych.2005.04.044_bib42
  article-title: Decreases in dopamine receptors but not in dopamine transporters in alcoholics
  publication-title: J Nucl Med
– volume: 116
  start-page: 163
  year: 2002
  ident: 10.1016/j.biopsych.2005.04.044_bib43
  article-title: Effects of alcohol detoxification on dopamine D2 receptors in alcoholics
  publication-title: Psychiatry Res
  doi: 10.1016/S0925-4927(02)00087-2
– volume: 44
  start-page: 326
  year: 1998
  ident: 10.1016/j.biopsych.2005.04.044_bib9
  article-title: Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography
  publication-title: Ann Neurol
  doi: 10.1002/ana.410440307
– volume: 161
  start-page: 1783
  year: 2004
  ident: 10.1016/j.biopsych.2005.04.044_bib12
  article-title: Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.161.10.1783
– volume: 42
  start-page: 719
  year: 1994
  ident: 10.1016/j.biopsych.2005.04.044_bib27
  article-title: The nucleus accumbens as a complex of functionally distinct neuronal ensembles
  publication-title: Prog Neurobiol
  doi: 10.1016/0301-0082(94)90025-6
– volume: 239
  start-page: 219
  year: 1986
  ident: 10.1016/j.biopsych.2005.04.044_bib16
  article-title: Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol
  publication-title: J Pharmacol Exp Ther
– volume: 10
  start-page: 387
  year: 1993
  ident: 10.1016/j.biopsych.2005.04.044_bib23
  article-title: Densities of dopamine D2 receptors are reduced in CNS regions of alcohol-preferring P rats
  publication-title: Alcohol
  doi: 10.1016/0741-8329(93)90025-J
– volume: 292
  start-page: 57
  year: 2000
  ident: 10.1016/j.biopsych.2005.04.044_bib18
  article-title: Specific binding and laterality of human extrastriatal dopamine D2/D3 receptors in late onset type 1 alcoholic patients
  publication-title: Neurosci Lett
  doi: 10.1016/S0304-3940(00)01423-3
– volume: 95
  start-page: S211
  issue: Suppl 2
  year: 2000
  ident: 10.1016/j.biopsych.2005.04.044_bib1
  article-title: Obsessive–compulsive aspects of craving
  publication-title: Addiction
  doi: 10.1046/j.1360-0443.95.8s2.9.x
– volume: 948
  start-page: 192
  year: 2002
  ident: 10.1016/j.biopsych.2005.04.044_bib6
  article-title: Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(02)03220-1
– volume: 17
  start-page: 162
  year: 1997
  ident: 10.1016/j.biopsych.2005.04.044_bib19
  article-title: Imaging D–2 receptor occupancy by endogenous dopamine in humans
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(97)00043-2
– volume: 127
  start-page: 1653
  year: 1971
  ident: 10.1016/j.biopsych.2005.04.044_bib31
  article-title: The Michigan alcoholism screening test
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.127.12.1653
– volume: 6
  start-page: 261
  year: 2001
  ident: 10.1016/j.biopsych.2005.04.044_bib39
  article-title: Dopamine D(2)/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4000859
– volume: 357
  start-page: 354
  year: 2001
  ident: 10.1016/j.biopsych.2005.04.044_bib45
  article-title: Brain dopamine and obesity
  publication-title: Lancet
  doi: 10.1016/S0140-6736(00)03643-6
– volume: 45
  start-page: 338
  year: 2004
  ident: 10.1016/j.biopsych.2005.04.044_bib15
  article-title: Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates
  publication-title: J Nucl Med
– volume: 116
  start-page: 285
  year: 1994
  ident: 10.1016/j.biopsych.2005.04.044_bib14
  article-title: Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/BF02245330
– volume: 29
  start-page: 169
  year: 1988
  ident: 10.1016/j.biopsych.2005.04.044_bib24
  article-title: Effects of acute ethanol administration on monoamine and metabolite content in forebrain regions of ethanol-tolerant and -nontolerant alcohol-preferring (P) rats
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(88)90291-2
– volume: 20
  start-page: 91
  year: 2003
  ident: 10.1016/j.biopsych.2005.04.044_bib38
  article-title: Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.10129
– volume: 23
  start-page: 285
  year: 2003
  ident: 10.1016/j.biopsych.2005.04.044_bib21
  article-title: Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1097/01.WCB.0000048520.34839.1A
– volume: 85
  start-page: 898
  year: 2003
  ident: 10.1016/j.biopsych.2005.04.044_bib26
  article-title: Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2003.01732.x
– volume: 91
  start-page: 199
  year: 1982
  ident: 10.1016/j.biopsych.2005.04.044_bib32
  article-title: Alcohol dependence syndrome
  publication-title: J Abnorm Psychol
  doi: 10.1037/0021-843X.91.3.199
– volume: 165
  start-page: 67
  year: 2002
  ident: 10.1016/j.biopsych.2005.04.044_bib4
  article-title: Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-002-1233-9
– volume: 347
  start-page: 146
  year: 1990
  ident: 10.1016/j.biopsych.2005.04.044_bib35
  article-title: Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics
  publication-title: Nature
  doi: 10.1038/347146a0
– volume: 2
  start-page: 118
  year: 1988
  ident: 10.1016/j.biopsych.2005.04.044_bib46
  article-title: The neurobiology of craving
  publication-title: J Abnorm Psychol
  doi: 10.1037/0021-843X.97.2.118
– volume: 49
  start-page: 226
  year: 2003
  ident: 10.1016/j.biopsych.2005.04.044_bib3
  article-title: Alcohol promotes dopamine release in the human nucleus accumbens
  publication-title: Synapse
  doi: 10.1002/syn.10226
– volume: 132
  start-page: 361
  year: 1997
  ident: 10.1016/j.biopsych.2005.04.044_bib13
  article-title: Effects of lorazepam administration on striatal dopamine D–2 receptor binding characteristics in man—a positron emission tomography study
  publication-title: Psychopharmacology
  doi: 10.1007/s002130050356
SSID ssj0007221
Score 2.3798537
Snippet A decrease in dopamine type 2 receptors (D 2 ) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D 2 receptors...
A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and...
Background A decrease in dopamine type 2 receptors (D sub(2)) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 779
SubjectTerms Addictive behaviors
Adult
Adult and adolescent clinical studies
Alcohol dependence
Alcoholism
Alcoholism - diagnosis
Alcoholism - diagnostic imaging
Alcoholism - metabolism
Alcoholism - physiopathology
amphetamine
Basal Ganglia - diagnostic imaging
Basal Ganglia - metabolism
Basal Ganglia - physiopathology
Biological and medical sciences
Carbon Radioisotopes
Dextroamphetamine - pharmacology
dopamine
Dopamine - metabolism
Dopamine - physiology
Female
Humans
Limbic System - drug effects
Limbic System - metabolism
Limbic System - physiopathology
Magnetic Resonance Imaging
Male
Medical sciences
mesolimbic
Middle Aged
Neural Inhibition - drug effects
Neural Inhibition - physiology
Neuropharmacology
Pharmacology. Drug treatments
positron emission tomography (PET)
Positron-Emission Tomography
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Raclopride
Receptors, Dopamine D2 - drug effects
Receptors, Dopamine D2 - metabolism
Synaptic Transmission - drug effects
Synaptic Transmission - physiology
ventral striatum
Title Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0006322305005640
https://dx.doi.org/10.1016/j.biopsych.2005.04.044
https://www.ncbi.nlm.nih.gov/pubmed/16018986
https://www.proquest.com/docview/19510626
https://www.proquest.com/docview/68835837
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB5VRTwkhCBQCI-wB65u_Jh9HUNKlYLaCxRV4mDZ610pVetEJDlw4bcza-829BAVCckXWzur1c54Zr59zAfwoSosckcaaHKVEkCxWaKbnCc8rdPKYE1W5oHi6ZmYnePnC36xB9N4F8Yfqwy-v_fpnbcOX8ZhNsfL-dzf8aXwStEt5b6eJXrcjii9lR_-3h7zkHkeWPNE4lv_dUv48rCeL7pDxWFtBenBXQHq8bJa0bS5nu9id0LaBabjp_AkZJRs0g_6GezZdgD3e47JXwN4OI2UbgN4cBp20p_Dj0nPjcuOAguusexkxaK2bMP8Ci37eLVp_csRYetrEmRdbKP-_CIbm7eM8kf2vV8hZl89Bch6c_0Czo8_fZvOkkC0kBhU-TrJnSgax7VxaYcBC1GrCtE4YXjRFF1VM5OTusmtVlIIRxgkt5lLURqVoywOYL9dtPYVMIOibrK01hwdFpXSrtFSS1ugy4zQ9RB4nN3ShCrkngzjqozHzS7LqBVPkcnLFOnBIYxv5JZ9HY47JWRUXhlvmZJfLClU3CmpbyRv2eI_yY5u2cl2sIRihNTpEN5HwylJW357pmrtYrMqM5_sEr7c3UIoypdVIYfwsre4be-Eq5VW4vV_DP0NPOrr0mZJxt_C_vrnxr6jjGtdj7pfagT3JidfZmd_AD6_Klg
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4hqpZKqGq3D5a24EOvYR3Hj_gIS9HSslwKFVIPVuLY0iLIrrq7By789o4Thy2HFZUq-ZIoY1meycx8fswH8KXIHBceNVCxnCJAcWmiKyYSQUtaWF6ilQWgOD6Xo0v-7UpcbcCwuwsTjlVG39_69MZbxzeDOJuD2WQS7vhieMXoRkWoZ8kRtz_j-PsGGoOD-9U5D8VYpM2TSfj8r2vC1wflZNqcKo6LKxwbXxehtmfFHOfNt4QX6zPSJjKdvIZXMaUkh-2o38CGq3vwvCWZvOvB1rDjdOvBi3HcSn8Lvw5bclxyHGlwrSOnc9Kpy1UkLNGSo5tlHR6OEVzfoiBpghv2F1bZyKQmmECSn-0SMfkROEAWy9t3cHny9WI4SiLTQmJ5zhYJ8zKrvNDW0wYEZrLMC86tl1ZkVdaUNbMM9Y1-tVBSegQhzKWecmVzxlX2Hjbrae12gFguyyqlpRbc86zIta-00spl3KdW6rIPoptdY2MZ8sCGcWO682bXptNK4MgUhnJsvA-DB7lZW4jjSQnVKc9010zRMRqMFU9K6gfJR8b4T7J7j-xkNViEMVJp2of9znAMaivszxS1my7nJg3ZLgLM9V_IHBPmPFN9-NBa3Kp3BNa5zuXufwx9H7ZGF-Mzc3Z6_v0jvGyL1KZJKj7B5uL30n3G9GtR7jW_1x_K9ivm
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alcohol+dependence+is+associated+with+blunted+dopamine+transmission+in+the+ventral+striatum&rft.jtitle=Biological+psychiatry+%281969%29&rft.au=MARTINEZ%2C+Diana&rft.au=GIL%2C+Roberto&rft.au=LARUELLE%2C+Marc&rft.au=ABI-DARGHAM%2C+Anissa&rft.date=2005-11-15&rft.pub=Elsevier+Science&rft.issn=0006-3223&rft.eissn=1873-2402&rft.volume=58&rft.issue=10&rft.spage=779&rft.epage=786&rft_id=info:doi/10.1016%2Fj.biopsych.2005.04.044&rft.externalDBID=n%2Fa&rft.externalDocID=17296790
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-3223&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-3223&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-3223&client=summon